Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs. The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development.
"synopsis" may belong to another edition of this title.
Hard to Find book
Stroke is the third largest cause of death in industrialized countries and the number one cause of disability in adults. Ischemic stroke constitutes approximately 80 per cent of all strokes. The successful tissue plasminogen activator (tPA) trials opened up a new era of stroke management, with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most up-to-date views on the clinical stroke trials and academic and industrial efforts to develop new drugs.
"About this title" may belong to another edition of this title.
Seller: Fine Press Bookshop, Stoney Creek, ON, Canada
Hardcover. Condition: Very Good. No Jacket. Monogreaphs in Clinical Neuroscience Vol. 16. Clean nicely bound copy. Unmarked text. price printed neatly on the ffep. Secure packaging! This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most up-to-date views on the clinical stroke trials and academic and industrial efforts to develop new drugs. g2. Book. Seller Inventory # 5989
Seller: Fine Press Bookshop, Stoney Creek, ON, Canada
Hardcover. Condition: Fine. No Jacket. Monogreaphs in Clinical Neuroscience Vol. 16. Clean copy still sealed in cellophane. Secure packaging! This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most up-to-date views on the clinical stroke trials and academic and industrial efforts to develop new drugs. g2. Book. Seller Inventory # 009902
Seller: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Seller Inventory # G3805565607I4N00
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book. Seller Inventory # ERICA82938055656073
Quantity: 1 available